NEW YORK (GenomeWeb News) – Clinical Data today reported that its fiscal fourth-quarter revenues doubled year over year as its quarterly net loss grew by 62 percent.

Revenue for the three months ended March 31 climbed 103 percent to $3.2 million from $1.6 million in the comparable period of 2008. The company attributed the increase to the expansion of its PGxHealth sales and marketing force and increased payor coverage during the last 18 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.